Certain New Chemicals or Significant New Uses; Statements of Findings for May, June, and July 2022, 51412-51413 [2022-18011]

Download as PDF 51412 Federal Register / Vol. 87, No. 161 / Monday, August 22, 2022 / Notices o. Final amendments to the application must be filed with the Commission no later than 30 days from the issuance date of the notice of ready for environmental analysis. Dated: August 16, 2022. Kimberly D. Bose, Secretary. [FR Doc. 2022–18067 Filed 8–19–22; 8:45 am] BILLING CODE 6717–01–P and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–1667; email address: edelstein.rebecca@epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: ENVIRONMENTAL PROTECTION AGENCY I. Executive Summary [EPA–HQ–OPPT–2022–0116; FRL–9412–16– OCSPP] Certain New Chemicals or Significant New Uses; Statements of Findings for May, June, and July 2022 Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from May 1, 2022 to July 31, 2022. ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2022–0116, is available online at https:// www.regulations.gov or in-person at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Rebecca Edelstein, New Chemical Division (7405M), Office of Pollution Prevention jspears on DSK121TN23PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:17 Aug 19, 2022 Jkt 256001 A. Does this action apply to me? This action provides information that is directed to the public in general. B. What action is the Agency taking? This document lists the statements of findings made by EPA after review of submissions under TSCA section 5(a) that certain new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA during the reporting period. C. What is the Agency’s authority for taking this action? TSCA section 5(a)(3) requires EPA to review a submission under TSCA section 5(a) and make one of the following specific findings: • The chemical substance or significant new use presents an unreasonable risk of injury to health or the environment; • The information available to EPA is insufficient to permit a reasoned evaluation of the health and environmental effects of the chemical substance or significant new use; • The information available to EPA is insufficient to permit a reasoned evaluation of the health and environmental effects and the chemical substance or significant new use may present an unreasonable risk of injury to health or the environment; • The chemical substance is or will be produced in substantial quantities, and such substance either enters or may reasonably be anticipated to enter the environment in substantial quantities or there is or may be significant or substantial human exposure to the substance; or • The chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Under TSCA, the unreasonable risk findings must be made without consideration of costs or other non-risk factors, including an unreasonable risk PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 to a potentially exposed or susceptible subpopulation identified as relevant under the conditions of use. The term ‘‘conditions of use’’ is defined in TSCA section 3 to mean ‘‘the circumstances, as determined by the Administrator, under which a chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of.’’ TSCA section 5(g) requires EPA to publish in the Federal Register a statement of its findings after its review of a submission under TSCA section 5(a) when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5. Anyone who plans to manufacture (which includes import) a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use. The submitter of a notice to EPA for which EPA has made a finding of ‘‘not likely to present an unreasonable risk of injury to health or the environment’’ may commence manufacture of the chemical substance or manufacture or processing for the significant new use notwithstanding any remaining portion of the applicable review period. II. Statements of Findings Under TSCA Section 5(a)(3)(C) In this unit, EPA provides the following information (to the extent that such information is not claimed as Confidential Business Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA section 5(a)(3)(C) that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment: The following list provides the EPA case number assigned to the TSCA section 5(a) submission and the chemical identity (generic name if the specific name is claimed as CBI). • J–22–0012, J–22–0013, Genetically modified microorganism for the production of a chemical substance (Generic Name). To access EPA’s decision document describing the basis of the ‘‘not likely to present an unreasonable risk’’ finding E:\FR\FM\22AUN1.SGM 22AUN1 Federal Register / Vol. 87, No. 161 / Monday, August 22, 2022 / Notices made by EPA under TSCA section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/ reviewing-new-chemicals-under-toxicsubstances-control-act-tsca/chemicalsdetermined-not-likely. Authority: 15 U.S.C. 2601 et seq. Dated: August 15, 2022. Madison Le, Director, New Chemicals Division, Office of Pollution Prevention and Toxics. telephone number: (202) 566–1030; email address: RDFRNotices@epa.gov. The mailing address for each contact person: Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. As part of the mailing address, include the contact person’s name, division, and mail code. SUPPLEMENTARY INFORMATION: I. General Information [FR Doc. 2022–18011 Filed 8–19–22; 8:45 am] A. Does this action apply to me? BILLING CODE 6560–50–P This action provides information that is directed to the public in general. ENVIRONMENTAL PROTECTION AGENCY B. What should I consider as I prepare my comments for EPA? jspears on DSK121TN23PROD with NOTICES [EPA–HQ–OPP–2022–0160; FRL–9409–04– OCSPP] 1. Submitting CBI. Do not submit CBI information to EPA through https:// www.regulations.gov/ or email. Clearly Pesticide Product Registration; mark the part or all of the information Receipt of Applications for New Active that you claim to be CBI. For CBI Ingredients—July 2022 information in a disk or CD–ROM that you mail to EPA, mark the outside of the AGENCY: Environmental Protection disk or CD–ROM as CBI and then Agency (EPA). identify electronically within the disk or ACTION: Notice. CD–ROM the specific information that SUMMARY: EPA has received applications is claimed as CBI. In addition to one to register pesticide products containing complete version of the comment that includes information claimed as CBI, a active ingredients not included in any copy of the comment that does not currently registered pesticide products. contain the information claimed as CBI Pursuant to the Federal Insecticide, must be submitted for inclusion in the Fungicide, and Rodenticide Act (FIFRA), EPA is hereby providing notice public docket. Information so marked will not be disclosed except in of receipt and opportunity to comment accordance with procedures set forth in on these applications. 40 CFR part 2. DATES: Comments must be received on 2. Tips for preparing your comments. or before September 21, 2022. When preparing and submitting your ADDRESSES: Submit your comments, comments, see the commenting tips at identified by the docket identification https://www.epa.gov/dockets/epa(ID) number and the EPA File Symbol or dockets. the EPA Registration Number of interest 3. Environmental justice. EPA seeks to as shown in the body of this document, achieve environmental justice, the fair through the Federal eRulemaking Portal treatment and meaningful involvement at https://www.regulations.gov. Follow of any group, including minority and/or the online instructions for submitting low-income populations, in the comments. Do not submit electronically development, implementation, and any information you consider to be enforcement of environmental laws, Confidential Business Information (CBI) regulations, and policies. To help or other information whose disclosure is address potential environmental justice restricted by statute. For the latest status issues, the Agency seeks information on information on EPA/DC services and any groups or segments of the access, visit https://www.epa.gov/ population who, as a result of their dockets. location, cultural practices, or other FOR FURTHER INFORMATION CONTACT: factors, may have atypical or Each application summary in Unit II disproportionately high and adverse specifies a contact division. The human health impacts or environmental appropriate division contacts are effects from exposure to the pesticides identified as follows: discussed in this document, compared • BPPD (Biopesticides and Pollution to the general population. Prevention Division) (Mail Code 7511M); Charles Smith; main telephone II. Registration Applications EPA has received applications to number: (202) 566–1400; email address: register pesticide products containing BPPDFRNotices@epa.gov. active ingredients not included in any • RD (Registration Division) (Mail Code 7505T); Marietta Echeverria; main currently registered pesticide products. VerDate Sep<11>2014 18:17 Aug 19, 2022 Jkt 256001 PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 51413 Pursuant to the provisions of FIFRA section 3(c)(4) (7 U.S.C. 136a(c)(4)), and 40 CFR 152.102, EPA is hereby providing notice of receipt and opportunity to comment on these applications. Notice of receipt of these applications does not imply a decision by the Agency on these applications. For actions being evaluated under EPA’s public participation process for registration actions, there will be an additional opportunity for public comment on the proposed decisions. Please see EPA’s public participation website for additional information on this process (https://www.epa.gov/ pesticide-registration/publicparticipation-process-registrationactions). New Active Ingredients File Symbols: 11603–AG, 66222–EOI, and 66222–EOT. Docket ID number: EPA–HQ–OPP–2022–0575. Applicant: ADAMA AGAN c/o Makhteshim Agan of North America, Inc. (d/b/a ADAMA), 3120 Highwoods Blvd., Suite 100 Raleigh, NC 27604. Product name: Metamitron Technical, ADA 46701 SC, and ADA 46343 SG. Active ingredient: herbicide—metamitron at 98.66%, 14.41%, and 15%, respectively. Proposed use: Pome Fruit (Crop Group 11–10). Contact: RD. File Symbol: 52991–UU. Docket ID number: EPA–HQ–OPP–2022–0659. Applicant: Bedoukian Research, Inc., 6 Commerce Drive, Danbury, CT 06810. Product name: Bedoukian Tuta Absoluta Technical Pheromone. Active ingredients: Insecticide—(e,z,z)-3,8,11Tetradecatrienyl acetate at 76.50% and (e,z)-3,8-Tetradecadienyl acetate at 9.30%. Proposed use: For use to manufacture end-use products intended to control the tomato leaf miner (Tuta absoluta). Contact: BPPD. Dated: August 10, 2022. Brian Bordelon, Acting Director, Information Technology and Resources Management Division, Office of Program Support. [FR Doc. 2022–18021 Filed 8–19–22; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [FRL–10131–01–R9] Revision of Approved State Primacy Program for the State of Hawaii Environmental Protection Agency (EPA). ACTION: Notice of approval. AGENCY: Notice is hereby given that the State of Hawaii revised its approved SUMMARY: E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 87, Number 161 (Monday, August 22, 2022)]
[Notices]
[Pages 51412-51413]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18011]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2022-0116; FRL-9412-16-OCSPP]


Certain New Chemicals or Significant New Uses; Statements of 
Findings for May, June, and July 2022

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to 
publish in the Federal Register a statement of its findings after its 
review of certain TSCA submissions when EPA makes a finding that a new 
chemical substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment. Such 
statements apply to premanufacture notices (PMNs), microbial commercial 
activity notices (MCANs), and significant new use notices (SNUNs) 
submitted to EPA under TSCA. This document presents statements of 
findings made by EPA on such submissions during the period from May 1, 
2022 to July 31, 2022.

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPPT-2022-0116, is available online 
at https://www.regulations.gov or in-person at the Office of Pollution 
Prevention and Toxics Docket (OPPT Docket), Environmental Protection 
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., 
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading 
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, 
excluding legal holidays. The telephone number for the Public Reading 
Room is (202) 566-1744, and the telephone number for the OPPT Docket is 
(202) 566-0280. For the latest status information on EPA/DC services 
and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: For technical information contact: 
Rebecca Edelstein, New Chemical Division (7405M), Office of Pollution 
Prevention and Toxics, Environmental Protection Agency, 1200 
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number: 
(202) 564-1667; email address: [email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. Executive Summary

A. Does this action apply to me?

    This action provides information that is directed to the public in 
general.

B. What action is the Agency taking?

    This document lists the statements of findings made by EPA after 
review of submissions under TSCA section 5(a) that certain new chemical 
substances or significant new uses are not likely to present an 
unreasonable risk of injury to health or the environment. This document 
presents statements of findings made by EPA during the reporting 
period.

C. What is the Agency's authority for taking this action?

    TSCA section 5(a)(3) requires EPA to review a submission under TSCA 
section 5(a) and make one of the following specific findings:
     The chemical substance or significant new use presents an 
unreasonable risk of injury to health or the environment;
     The information available to EPA is insufficient to permit 
a reasoned evaluation of the health and environmental effects of the 
chemical substance or significant new use;
     The information available to EPA is insufficient to permit 
a reasoned evaluation of the health and environmental effects and the 
chemical substance or significant new use may present an unreasonable 
risk of injury to health or the environment;
     The chemical substance is or will be produced in 
substantial quantities, and such substance either enters or may 
reasonably be anticipated to enter the environment in substantial 
quantities or there is or may be significant or substantial human 
exposure to the substance; or
     The chemical substance or significant new use is not 
likely to present an unreasonable risk of injury to health or the 
environment.
    Under TSCA, the unreasonable risk findings must be made without 
consideration of costs or other non-risk factors, including an 
unreasonable risk to a potentially exposed or susceptible subpopulation 
identified as relevant under the conditions of use. The term 
``conditions of use'' is defined in TSCA section 3 to mean ``the 
circumstances, as determined by the Administrator, under which a 
chemical substance is intended, known, or reasonably foreseen to be 
manufactured, processed, distributed in commerce, used, or disposed 
of.''
    TSCA section 5(g) requires EPA to publish in the Federal Register a 
statement of its findings after its review of a submission under TSCA 
section 5(a) when EPA makes a finding that a new chemical substance or 
significant new use is not likely to present an unreasonable risk of 
injury to health or the environment. Such statements apply to PMNs, 
MCANs, and SNUNs submitted to EPA under TSCA section 5.
    Anyone who plans to manufacture (which includes import) a new 
chemical substance for a non-exempt commercial purpose and any 
manufacturer or processor wishing to engage in a use of a chemical 
substance designated by EPA as a significant new use must submit a 
notice to EPA at least 90 days before commencing manufacture of the new 
chemical substance or before engaging in the significant new use.
    The submitter of a notice to EPA for which EPA has made a finding 
of ``not likely to present an unreasonable risk of injury to health or 
the environment'' may commence manufacture of the chemical substance or 
manufacture or processing for the significant new use notwithstanding 
any remaining portion of the applicable review period.

II. Statements of Findings Under TSCA Section 5(a)(3)(C)

    In this unit, EPA provides the following information (to the extent 
that such information is not claimed as Confidential Business 
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this 
period, EPA has made findings under TSCA section 5(a)(3)(C) that the 
new chemical substances or significant new uses are not likely to 
present an unreasonable risk of injury to health or the environment:
    The following list provides the EPA case number assigned to the 
TSCA section 5(a) submission and the chemical identity (generic name if 
the specific name is claimed as CBI).
     J-22-0012, J-22-0013, Genetically modified microorganism 
for the production of a chemical substance (Generic Name).
    To access EPA's decision document describing the basis of the ``not 
likely to present an unreasonable risk'' finding

[[Page 51413]]

made by EPA under TSCA section 5(a)(3)(C), look up the specific case 
number at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/chemicals-determined-not-likely.
    Authority: 15 U.S.C. 2601 et seq.

    Dated: August 15, 2022.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. 2022-18011 Filed 8-19-22; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.